Cambrian Biopharma's James Peyer: "70 will be the new 50"
The Sunday Times’ tech correspondent brings on James Peyer, co-founder of Cambrian Biopharma, to talk about the unique structure of his startup (6:30), the goal (8:45), alighting on longevity as a 15-year-old (12:45), why the field has matured (15:40), what he chooses to focus on (19:50), getting drugs to market…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Times Tech
See all episodes →
Why OpenAI and Anthropic should fear Meta Muse
The Interview: Nu Quantum CEO on how quantum computing could solve the energy crisis
The Interview: Nu Quantum CEO on how quantum computing could solve nature’s problems
Similar episodes from other shows
More like Times Tech →
Longevity: Can We Add Another 30 Years? | The Decade Ahead
Tech Tonic: Defying death
David Sinclair || Why We Age and Why We Don’t Have To
Defying death: The future of forever
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.